...+ S&P Global Ratings revised its outlook to stable from negative and affirmed its '##-' long-term rating on the Oklahoma Development Finance Authority's series 2018B tax-exempt fixed-rate bonds and series 2018C taxable fixed-rate bonds, issued for OU Medicine Inc. (OUMI), now doing business as OU Health. + In addition, we affirmed our '##-' underlying rating (SPUR) on the insured maturities of the authority's series 2018B and 2018C bonds, also issued for OUMI. + The outlook on all ratings, where applicable, is stable. + The stable outlook reflects our view that the financial profile has largely stabilized, with no further declines in year-end unrestricted reserves or added debt expected. In addition, despite immense sector labor and inflationary pressures, operations remained fairly resilient in fiscal 2023 supporting projected year-end debt service coverage of 1.5x. Management also notes compliance with its 45 days' cash on hand (DCOH) covenant for fiscal 2023, with further reserve tailwinds...
